Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Completed Trials

You can find out about each of our completed trials by clicking on the tiles below. Trials which are ongoing or in follow-up can be found on our Current Trials page.

Recently Completed Trials

In set up (2).png

wingmen_listing_16X9.pngWINGMEN: Windows trial of INsulin-like Growth factor neutralising antibody Xentuzumab in MEN scheduled for radical prostatectomy

In set up (2).png

Ceedd_listing_16x9.pngCEeDD: Sonosensitive particles and ultrasound to enhance drug delivery in metastatic colorectal cancer

In set up (2).png

SYMPLIFY Listing ImageSYMPLIFY - Observational study to assess a multi-cancer early detection test in individuals referred with signs and symptoms of cancer

In set up (2).png

emerald_pancreas_16_9.pngEMERALD Pancreas: Evaluation of hypofractionated adaptive radiotherapy using the MR Linac in localised pancreatic cancer

In set up (2).png

ARCADIAN Listing.pngARCADIAN: Atovaquone with Radical ChemorADIotherapy in locally Advanced NSCLC

In set up (2).png

cedar_16_9.pngCEDAR: Chemoradiation with Enadenotucirev as a radiosensitiser in locally Advanced Rectal cancer

All Completed Trials

6MP: A Phase II Clinical Trial in Patients with BRCA Defective Tumours

ARCADIAN: Atovaquone with Radical ChemorADIotherapy in locally Advanced NSCLC

ART: Anal squamous cell carcinoma: Investigation of functional imaging during chemoRadioTherapy

AspECT: A Phase III, Randomised, study of Aspirin and Esomeprazole Chemoprevention in Barrett’s Metaplasia

ATOM: Atovaquone as Tumour HypOxia Modifier

BKM120: Palliative thoracic radiotherapy plus BKM120

CAMELLIA: Anti-CD47 antibody terapy in relapsed/refractory Haematological Malignancies

CEDAR: Chemoradiation with Enadenotucirev as a radiosensitiser in locally Advanced Rectal cancer

CEeDD: Sonosensitive particles and ultrasound to enhance drug delivery in metastatic colorectal cancer

CHARIOT: M6620 plus standard treatment in oesophageal and other cancer

CHOP-OR: Study of CHOP with Ofatumumab in Patients with Richter's Syndrome

COG : Gefitinib for oesophageal cancer progressing after chemotherapy

CYTOFLOC: Cytosponge™ for post‐chemoradiation surveillance of oesophageal cancer

DATACAP: Dose Adaptation of Capecitabine Using Mobile Phone Toxicity Monitoring

DEBIOC: Dual Erb B Inhibition in Oesophago-gastric Cancer

DOC-MEK: A double-blind randomized phase 2 trial of docetaxel with or without selumetinib in wild-type BRAF advanced melanoma

EMERALD Pancreas: Evaluation of hypofractionated adaptive radiotherapy using the MR Linac in localised pancreatic cancer

EnROL: Conventional versus laproscopic surgery for colorectal cancer within an enhanced programme

FOXFIRE: An open-label randomised phase III trial of 5-Fluorouracil, OXaliplatin and Folinic acid +/- Interventional Radio-Embolisation as first line treatment for patients with unresectable liver-only or liver-predominant metastatic colorectal cancer

FRONTIER: Fluciclovine (18F) imaging of breast cancer

IMAGO: A single arm exploratory study examining the feasibility of imaging glioblastoma pH using CEST MRI

IPI-GLIO trial logo

IpiGlio: A Phase II, Open Label, Randomised Study of Ipilimumab with Temozolomide versus Temozolomide alone after surgery and chemoradiotherapy in patients with recently diagnosed glioblastoma

LINES: Eurosarc Trial of Linsitinib in advanced Ewing Sarcoma

LUD 2015-005: ANTI-PD-L1 in combination with chemo(radio)therapy for oesophageal cancer

MErCuRIC1: MEK and MET Inhibition in Colorectal Cance

MPP: Application of mobile phone technology for managing chemotherapy-associated side-effects

NEOPANC-01 - Pre-operative, Window-of-opportunity Study to Assess Gene Expression in Patients With Resectable, Locally Advanced, or Metastatic Pancreatic Cancer

NuTide:301: Safety, pharmacokinetics and clinical activity of NUC-3373, a nucleotide analogue, in participants with advanced solid tumours.

OCTOVA: Paclitaxel, olaparib and cediranib in platinum-resistant ovarian cancer.

OXO-PCR-01: Oxford Ovarian Cancer Predict Chemotherapy Response 01

PACMEL: A randomised phase 2 study of paclitaxel with or without GSK1120212 or pazopanib in advanced wt BRAF melanoma

PanDox : Feasibility of Enhanced Chemotherapy Delivery to non-resectable Primary Pancreatic Tumours Using Thermosensitive Liposomal Doxorubicin (ThermoDox®) and Focused Ultrasound

PemBla: A parallel group phase I/II marker lesion study to assess the safety, tolerability and efficacy of intravenous or intravesical pembrolizumab in intermediate risk recurrent non-muscle invasive bladder cancer

QUASAR2: Multicentre international study of capecitabine ± bevacizumab as adjuvant treatment of colorectal cancer

RADVAN: A randomised double blind phase 2 trial of whole brain radiotherapy with or without vandetanib in metastatic melanoma with brain metastases.

RHYTHM-1: Modulation of Radiotherapy according to HYpoxia: exploiting changes in the Tumour Microenvironment to improve outcome in rectal cancer